Takayoshi Morita

Visiting Professor

Osaka University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Takayoshi Morita is a Visiting Professor at The University of Osaka, Japan. His research focuses on immunology and therapeutic interventions in various inflammatory conditions, including psoriatic arthritis, systemic lupus erythematosus, and COVID-19. He has contributed to several systematic reviews and meta-analyses assessing the efficacy of targeted treatments and vaccine responses in immunocompromised populations.

Articles (8)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Yusuke Takeshima

Specially Appointed Assistant Professor

Osaka University

JAPAN

View details

Yu-Chen Liu

Specially Appointed Assitant Professor

Osaka University

JAPAN

View details

Shuhei Sakakibara

Assistant Professor

Osaka University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takayoshi Morita

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Therapeutic efficacy of molecular-targeted drugs for enthesitis in patients with PsA: a network meta-analysis

The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus

Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells

A case of Takayasu arteritis complicated with pulmonary infarction

Duration of SARS-CoV-2 RNA positivity from various specimens and clinical characteristics in patients with COVID-19: a systematic review and meta-analysis

Rapid attenuation of anti‐SARS‐CoV ‐2 antibody in patients with musculoskeletal diseases who reinitiated intensive immunosuppressive therapies after COVID ‐19.

Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis

Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody-associated vasculitis—a meta-analysis

Collaborators (3)

Yusuke Takeshima

Yu-Chen Liu

Shuhei Sakakibara

Make your next move.